Written by Klarity Editorial Team
Published: Jul 14, 2026

Last updated: July 14, 2026
If you have UnitedHealthcare (UHC) coverage in West Virginia and are managing generalized anxiety disorder, panic disorder, social anxiety, PTSD, OCD, or another anxiety condition, understanding your benefits before you book an appointment can save you time, stress, and unexpected costs. This guide explains how UHC typically covers anxiety treatment in West Virginia in 2026 — including therapy, medication, and telehealth — based on the state’s parity law, federal mental health parity rules, and OptumRx formulary standards.
Not sure if your plan covers anxiety treatment? Connect with a licensed Klarity provider to verify your benefits and get started with an anxiety evaluation — often without leaving home.
Coverage varies by plan. Always verify your specific benefits with UHC before booking.
West Virginia requires health benefit plans to provide mental health and substance use disorder (MH/SUD) benefits that are no more restrictive than benefits for comparable medical or surgical conditions. The primary statute is W. Va. Code § 33-25-8r et seq., which applies to fully insured commercial health plans issued or delivered in West Virginia. Related provisions appear in § 33-25A (HMO plans) and § 33-16-3p (group health plans).
What this means in practice: if UHC covers 30 outpatient medical visits per year, it typically must cover at least the same number of outpatient behavioral health visits. Copays, deductibles, and prior authorization (PA) requirements for anxiety treatment must be comparable to those applied to analogous medical benefits.
The federal Mental Health Parity and Addiction Equity Act (MHPAEA) extends parity protections to self-funded employer plans, which are governed by ERISA and exempt from West Virginia’s state parity statute. This distinction is especially relevant in West Virginia, where the coal mining, natural gas (including Marcellus Shale operations), chemical manufacturing, and general manufacturing sectors employ a large share of the workforce in large self-funded ERISA plans. If your coverage comes through a self-funded employer group plan, MHPAEA governs rather than W. Va. Code § 33-25-8r — the protections are broadly similar, but enforcement routes differ. When in doubt, review your Summary Plan Description (SPD) or contact UHC directly.
UnitedHealthcare commercial plans in West Virginia typically include coverage for a wide range of anxiety-related services, though the specific benefits depend on your plan type (HMO, PPO, EPO), your deductible status, and whether the provider is in-network:
UHC uses OptumRx as its pharmacy benefit manager (PBM). The formulary tier your anxiety medication falls into determines your out-of-pocket cost. The table below reflects typical OptumRx commercial formulary placement for common anxiety medications in 2026; your specific plan may vary.
| Medication | Drug Class | Typical Tier | PA Required? |
|---|---|---|---|
| Generic SSRIs (sertraline, escitalopram, fluoxetine, paroxetine, citalopram) | SSRI antidepressant / anxiety | Tier 1–2 | Generally no |
| Generic SNRIs (venlafaxine ER, duloxetine) | SNRI antidepressant / anxiety | Tier 1–2 | Generally no |
| Buspirone (generic) | Anxiolytic (non-benzo) | Tier 1 | No |
| Hydroxyzine (generic) | Antihistamine / anxiolytic | Tier 1 | No |
| Propranolol (generic) | Beta-blocker (off-label situational anxiety) | Tier 1–2 | Generally no |
| Brand-name SSRIs (Lexapro brand, Zoloft brand, Paxil CR) | SSRI | Tier 3–4 | Typically yes — step therapy (generic trial required first) |
| Brand-name SNRIs (Effexor XR brand, Cymbalta brand) | SNRI | Tier 3–4 | Typically yes — step therapy |
| Benzodiazepines — Schedule IV (alprazolam, lorazepam, clonazepam, diazepam) | Benzodiazepine anxiolytic | Tier 2 | Generally no, but quantity limits typically apply |
| Pregabalin (Lyrica generic) — Schedule V | Anticonvulsant (off-label GAD) | Tier 2–3 | Sometimes — verify with plan |
| Vistaril / Atarax (brand hydroxyzine) | Antihistamine / anxiolytic (brand) | Tier 3 | Sometimes — generic preferred |
Formulary placements are subject to change. Verify your specific drug and dosage at OptumRx.com or by calling 1-800-788-4863.
West Virginia enacted one of the broadest electronic prescribing mandates in the country. Under W. Va. Code § 60A-4-403a, electronic prescribing is required for all controlled substances — not just Schedule II drugs. This is broader than many other states, which limit EPCS requirements to Schedule II only.
For anxiety treatment, here is how this applies:
In practice, most telehealth platforms including Klarity already use electronic prescribing infrastructure for all prescriptions, so this requirement rarely creates access barriers for patients. However, if you use an in-person prescriber who is not yet compliant with EPCS for controlled substance categories beyond Schedule II, this may affect how your benzo prescription is processed.
If your medication requires prior authorization, UHC and OptumRx follow a defined timeline:
Therapy is often the first-line treatment for anxiety disorders, and UHC typically covers outpatient mental health therapy under the same cost-sharing structure as other outpatient specialty care. Common modalities that may be covered:
The number of covered sessions per year, your copay per session, and whether you need a referral depend on your specific plan. PPO and EPO members typically do not need a referral for outpatient behavioral health; HMO members may need to start with their primary care physician (PCP).
Klarity Health connects patients in West Virginia with a network of 2,000+ licensed providers who can evaluate and treat anxiety disorders via telehealth. Klarity providers can prescribe non-controlled anxiety medications (SSRIs, SNRIs, buspirone, hydroxyzine) and can coordinate with your UHC plan for prior authorization when needed.
Ready to get started? See if you may qualify for anxiety treatment through Klarity — many patients are matched with a provider within days.
Klarity is in-network with select UHC plans. Verify your specific coverage before booking.
Most UHC plans include a deductible that applies to outpatient prescriptions unless the medication is on a preventive-care list. Generic SSRIs and SNRIs are often available at low Tier 1–2 cost-sharing, which may be below or count toward your deductible. Check your specific plan’s Summary of Benefits and Coverage (SBC) for exact cost-sharing amounts.
UHC PPO and EPO plan members typically do not need a referral to see an in-network behavioral health specialist. HMO members may need a referral from their PCP. Check your Evidence of Coverage document or call 1-866-892-5890 to confirm your plan’s referral requirements.
W. Va. Code § 33-25-8r et seq. requires that MH/SUD benefits not be more restrictive than comparable medical benefits, which typically means benzodiazepines should be covered at formulary tiers comparable to other prescription drugs. However, OptumRx typically applies quantity limits to benzodiazepines given their Schedule IV controlled substance status. These quantity limits are a standard benefit design feature that may be permissible under parity rules if applied consistently. Your plan documents will specify the exact quantity limits.
Klarity providers can prescribe non-controlled anxiety medications (SSRIs, SNRIs, buspirone, hydroxyzine) via telehealth in West Virginia. For controlled substances such as benzodiazepines, federal and state telehealth prescribing rules, including Ryan Haight Act provisions and post-COVID telehealth extensions, govern what can be prescribed. Verify with your Klarity provider at your initial visit what medications are available through telehealth. W. Va. Code § 60A-4-403a requires EPCS for all controlled substances, which Klarity’s platform already supports.
If UHC or OptumRx denies PA for an anxiety medication, you have the right to file an internal appeal. Your provider can submit clinical documentation supporting medical necessity. If the internal appeal is also denied, you may request an independent external review through UHC. If you believe the denial violates W. Va. Code § 33-25-8r parity requirements, you may also file a complaint with the West Virginia Insurance Commissioner at 1-888-879-9842 or wvinsurance.gov. For ERISA self-funded plan members, the U.S. Department of Labor’s Employee Benefits Security Administration (EBSA) handles complaints.
Disclaimer: This article is for informational purposes only and does not constitute legal, medical, or insurance advice. Coverage for anxiety treatment varies by UHC plan type, employer group, and individual circumstances. The information reflects general knowledge about UHC and OptumRx practices as of July 2026 and may not reflect your specific plan. Always verify your benefits directly with UHC at 1-866-892-5890 before beginning treatment. OptumRx formulary placements are subject to change without notice. The West Virginia Insurance Commissioner’s office can assist with parity compliance questions.
Find the right provider for your needs — select your state to find expert care near you.